In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates. 3M announced that the Food and Drug Administration (FDA) has approved an ...
Tegaderm CHG IV securement dressing (3M) is a sterile, semi-permeable polyurethane adhesive dressing with an integrated gel pad containing 2% w/w chlorhexidine gluconate (CHG). It is used to secure ...
3M PICC / CVC Securement Device + Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M). 3M’s PICC / CVC Securement Device secures an IV without sutures using silicone adhesives. The ...
The global IV therapy and vein access devices market is projected to reach an impressive USD 28.7 billion by 2024, with a forecasted growth rate of 5.1% CAGR, bringing the market value to an estimated ...